Ocular Therapeutix Inc. diskutieren
Ocular Therapeutix Inc.
WKN: A1180P / Symbol: OCUL / Name: Ocular / Aktie / Ausrüstung & Versorgung / Small Cap /
5,70 €
-1,42 %
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "outperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $18.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target raised by analysts at Piper Sandler from $10.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for OCUL provided by MarketBeat
Ocular Therapeutix, Inc. (NASDAQ: OCUL) had its price target lowered by analysts at HC Wainwright from $16.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for OCUL provided by MarketBeat
Neueste Beiträge
Benchmark_Co_ in Baidu Inc. A ADR diskutieren